Search

Your search keyword '"Kasikova L"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Kasikova L" Remove constraint Author: "Kasikova L"
19 results on '"Kasikova L"'

Search Results

2. P03.24 Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients

3. Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.

4. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.

5. Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.

6. Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines.

7. An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.

8. Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.

9. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.

10. Detection of immunogenic cell death and its relevance for cancer therapy.

11. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.

12. Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.

13. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death.

14. Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood.

15. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients.

16. TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer.

17. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.

18. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.

19. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Catalog

Books, media, physical & digital resources